艾司氯胺酮在胸科手术中的临床应用进展

佳慧 赵(承德医学院附属医院，中国)
建玲 李(承德医学院附属医院，中国)

摘要

近年来，随着医学技术水平的提升，行胸腔镜下肺叶切除手术的患者逐年增多。而此类患者围手术期存在急慢性疼痛、炎症反应、氧化应激反应、术后抑郁情绪、术后认知障碍等问题，艾司氯胺酮是近年来新上市的药物，是氯胺酮的异构体，具有镇静、镇痛作用的同时，在抗炎、抗氧化应激、缓解焦虑抑郁等其他方面也有巨大潜力，并在肺癌根治术中展现出良好的临床价值。论文主要就艾司氯胺酮的药理学特性，以及经胸腔镜下肺癌根治术中的运用及作用进行综述，为临床应用进一步提供借鉴和参考。

关键词

艾司氯胺酮；胸科手术；临床应用；麻醉

参考

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021 May,71(3):209-249.

Peter M Rodgers-Fischl, Jeremiah T Martin, Sibu P Saha. Video-Assisted Thoracoscopic versus Open Lobectomy: Costs and Outcomes[J]. Southern medical journal, 2017,Vol.110(No.3):229-233.

耿耿,陶勇,吴家远,等.单操作孔电视胸腔镜肺叶切除术治疗早期肺癌预后的影响因素[J].中国老年学杂志,2022,42(6):1358-1360.

魏霄.亚麻醉剂量艾司氯胺酮对胸腔镜手术后阿片类药物镇痛消耗量的影响[J].智慧健康,2023,9(9):137-141.

Zeng X, Zhang X, Jiang W, et al. Efficacy of Intravenous Administration of Esketamine in Preventing and Treating Rebound Pain After Thoracic Paravertebral Nerve Block: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial[J]. Drug Des Devel Ther, 2024 Feb 17;18:463-473.

Argiriadou H, Himmelseher S, Papagiannopoulou P, et al. Improvement of pain treatment after major abdominal surgery by intravenous S+-ketamine[J].Anesth Analg, 2004 May,98(5):1413-8, table of contents.

Trimmel H, Helbok R, Staudinger T, et al. S(+)-ketamine : Current trends in emergency and intensive care medicine[J]. Wien Klin Wochenschr, 2018 May;130(9-10):356-366.

王凯,李宝强,葛磊,等.超声引导下罗哌卡因联合艾司氯胺酮椎旁阻滞技术在胸腔镜肺叶切除术中的应用价值[J].生物医学工程与临床,2023,27(3):310-315.

Zeng X, Zhang X, Jiang W, et al. Efficacy of Intravenous Administration of Esketamine in Preventing and Treating Rebound Pain After Thoracic Paravertebral Nerve Block: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial[J]. Drug Des Devel Ther, 2024 Feb 17;18:463-473.

Vinod K, Kurhekar P, Sharanya K, et al. Efficacy of the Stellate Ganglion Block Through the Lateral Approach Using Ultrasonogram and Fluoroscopy[J]. Turk J Anaesthesiol Reanim, 2018 Sep;46(5):393-398.

Brown LM, Kratz A, Verba S, et al. Pain and Opioid Use After Thoracic Surgery: Where We Are and Where We Need To Go[J]. Ann Thorac Surg, 2020 Jun;109(6):1638-1645.

Kreutzwiser D, Tawfic QA. Expanding Role of NMDA Receptor Antagonists in the Management of Pain[J]. CNS Drugs, 2019 Apr;33(4):347-374.

邱凤,王子申.艾司氯胺酮复合舒芬太尼对脊柱融合术患者术后疼痛的影响[J].山东第一医科大学(山东省医学科学院)学报,2022,43(2):116-119.

周珑艳,刘咏春,卢锡华,等.艾司氯胺酮对胸腔镜肺叶切除术后疼痛及炎症应激的影响[J].重庆医学,2023,52(19):2924-2929.

颜景佳,黄琦萍,陈清霞,等.艾司氯胺酮或纳布啡用于胸椎旁阻滞前的镇痛效果及对R-A-A-S的影响[J].重庆医学,2022,51(5):820-824.

Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms[J]. Pharmacol Rep, 2021 Apr;73(2):323-345.

高静静,钱向东,周海鸥.小剂量艾司氯胺酮对胸腔镜患者术后镇痛及炎症因子的影响[J].中国药房,2023,34(6):719-723.

沈凯,王淼,肖英,等.艾司氯胺酮联合普瑞巴林对胸腔镜术后急慢性疼痛的影响[J].临床麻醉学杂志,2023,39(12):1265-1269.

蔡雪姣,杜伯祥.艾司氯胺酮复合麻醉对胸腔镜肺叶切除术患者术中血流动力学和术后镇痛的影响[J].新疆医科大学学报,2023,46(7):937-941.

王亭.艾司氯胺酮与阿片类药物对全麻腹腔镜手术患者细胞免疫及IL-6、IL-10的影响[D].太原:山西医科大学,2021.

Hamaji M, Matsuo Y, Chen-Yoshikawa TF, et al. Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses[J]. J Thorac Dis, 2019 Aug;11(Suppl 13):S1646-S1652.

Zanos P, Moaddel R, Morris PJ, et al. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms[J]. Pharmacol Rev, 2018 Jul;70(3):621-660.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i11.22419